Regenosca

Regenosca  Seamless Tissue Regeneration

Regenosca provides regenerative medicine technology that enables permanent regrowth of your own native tissues on a self-absorbing mesh, ensuring seamless healing of soft tissue defects and surgical wounds. Our solutions are cost-effective, safe, and designed with surgeons in mind.
TissueSpan is an innovative, natural mesh designed to support seamless soft tissue repair and function as a protective barrier. While not a living tissue, it is engineered to actively attract and organize the patient's own cells upon implantation, initiating the body's natural regenerative processes. Fully absorbable, off-the-shelf, and ready-to-use, TissueSpan ensures easy clinical translation and compatibility with current surgical techniques.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
Deal

24.07.2024

Closing of pre-seed round

Milestone

15.10.2023

All patients of First-in-Human study operated

Deal

01.04.2023

KOL is joining FIrst-in-Human study as investigator

Deal

04.10.2022

Closing of convertible loan with private investors

Deal

30.08.2022

First patients operated in a First-in-Human study

Show more...

No Jobs

No videos and documents

Venture Leaders Medtech

Regenosca

Regenosca  Seamless Tissue Regeneration

Headquarter:
Lausanne

Foundation Date:
January 2019

Technology:

  • Medtech

Sectors:

  • Medical devices
  • Medtech
  • Urology

Support received

  • Support venture leaders
  • Support venturekick